赋予药剂师在2型糖尿病护理中的权力:预防,咨询和治疗优化的机会
Sarah Uddin1, Mathias Sanchez Machado1, Bayan Alshahrouri1
1Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA 19140, USA.
Journal of clinical medicine
|June 13, 2025
概括
药剂师可以通过早期检测,增强坚持和更好的血糖控制,显著改善2型糖尿病 (T2D) 管理. 整合更新的指导方针使药剂师能够领导关键干预措施,以获得最佳的患者结果.
科学领域:
- 药理学和制药科学 药理学和制药科学
- 公共卫生和流行病学
- 内分泌学和新陈代谢学
背景情况:
- 糖尿病是一种重大的全球健康挑战,增加了医疗保健负担.
- 药剂师处于一个独特的位置,可以在药物发行之外为糖尿病护理做出贡献.
- 糖尿病患病率的升级需要加强药剂师的策略,与当前的指导方针保持一致,例如美国糖尿病协会 (ADA) 2024.
研究的目的:
- 为药剂师提供关于优化2型糖尿病 (T2D) 管理的指南.
- 要突出关键的基础元素和有效的T2D控制的五个关键步骤.
- 强调药剂师在预防,检测,治疗管理和患者咨询方面的作用.
主要方法:
- 从2010年1月到2025年3月的PubMed,CDC和WHO指南的文献搜索.
- 关键词包括"药剂师"",2型糖尿病"",糖尿病预防"",药剂师干预"和"糖尿病管理".
- 纳入标准侧重于药剂师领导的T2D预防,干预或管理的英语研究;1型糖尿病研究被排除在外.
主要成果:
- 药剂师主导的护理模型显示了改善早期T2D检测的潜力.
- 有证据表明,在药剂师管理的T2D患者中,药物坚持度提高,血糖控制改善.
- 药剂师的干预可以提高整体治疗效率,并减少与糖尿病相关的并发症.
结论:
- 药剂师在诊断,预防,管理和缓解T2D后果方面至关重要.
- 加强药剂师的培训和参与,可以改善治疗结果.
- 药剂师在通过积极和全面的护理策略来减轻糖尿病负担方面发挥着至关重要的作用.
相关概念视频
Diabetes: Management and Pharmacotherapy
246
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
246
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Insulin: Dosing Regimen and Adverse Effects
161
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
161


